corporations

Belvedere Pharma is no longer on the list of entities licensed by Infarmed

Published

2 months ago

October

Reading Time: 2 minutes

Belvedere Pharma, authorized in 2023 to cultivate, import, and export cannabis for medicinal purposes, is no longer on the public list of entities licensed by Infarmed. After official contact with the company, it confirmed that it is in the process of requesting a license renewal and updating its technical staff, which is the reason for its absence.

As part of CannaReporter's monitoring of Infarmed's official listings, it was found that Belvedere Pharma does not appear on the list currently made publicly available by the national pharmaceutical authority. The company obtained a license in July 2023 to cultivate, import, and export medicinal cannabis for a one-year, renewable period, in accordance with Notice No. 18691/2023 of September 28, published in the Official Gazette.

Since licensing is annual and dependent on a renewal request, the absence may be related to the status of the renewal process, which would not be unprecedented. Although it has not yet been possible to determine the cause of this absence from the parties involved, it may be related to delays in updating listings, pending procedures, or other administrative changes to the license status.

To date, no official statement has been released to clarify this situation, and because it was the weekend, we were unable to contact either Infarmed or Belvedere Pharma. According to sources close to the company, it was unofficially confirmed that the company was in the process of renewing its license.

Due to official contact with the company, obtained after the publication of this article, namely with the future technical director of Belvedere, we obtained official confirmation that “Belvedere is not currently on the Infarmed list, as it is in the process of renewing (its license) as CannaReporter had already reported”.

CannaReporter will continue to analyze and cross-reference data from the sector and will monitor this topic.

This research is only possible thanks to the support of our readers. Become a patron, support independent journalism, and follow the developments in licensing through our platform, developed to ensure transparency and monitor the medicinal cannabis market in Portugal.
______________________________________________________________________________________________

Editor's Note:
1. The article was changed at 21:34 pm on October 26th to include unofficial confirmation from a source linked to the company that the license will be up for renewal.
2. The article was changed at 10:39 am on October 27th to include official confirmation from a source linked to the company, namely the future technical director, with the information that the license will be renewed as well as the company's technical staff.

____________________________________________________________________________________________________

[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]

____________________________________________________________________________________________________

What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

Antonio João Costa

I am one of the directors of CannaReporter, which I founded together with Laura Ramos. I am from the unique Island of Madeira, where I currently reside. While I was in Lisbon at FCUL studying Physical Engineering, I became involved in the national hemp and cannabis scene and participated in several associations, some of which I am still a member of. I follow the global industry and especially legislative advances regarding the different uses of cannabis.

I can be contacted by email at joao.costa@cannareporter.eu

Advertise with us!

Support independent journalism about cannabis.

Cannareporter needs you to continue informing.

If our work helps you stay up-to-date on cannabis policy, science, and industry, please consider supporting us with a monthly contribution on Patreon. Every contribution counts to keep the project free and independent.

Support us on Patreon

You can cancel your support at any time. Thank you for being part of our community.